HELIUS Trademark

Trademark Overview


On Wednesday, December 18, 2019, a trademark application was filed for HELIUS with the United States Patent and Trademark Office. The USPTO has given the HELIUS trademark a serial number of 79285417. The federal status of this trademark filing is REGISTERED as of Tuesday, December 7, 2021. This trademark is owned by HELIUS THERAPEUTICS LIMITED. The HELIUS trademark is filed in the Chemical Products, Pharmaceutical Products, Advertising, Business and Retail Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; medicinal preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; herbal preparations and extracts for medicinal use; medical cannabis and derivatives thereof namely, medicinal herbs and medicinal herb extracts; herbal supplements; all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of ...

Retail and wholesale store services featuring cannabis medicinal herbs, cannabis oil and derivatives thereof all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; retail and wholesale store services featuring hemp and cannabis cosmetic products and accessories, food products, beverages, personal care preparations, and skin care preparations, all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; providing consumer information featuring the ratings, reviews and recommendations on marijuana and medical marijuana products via a website

Active chemical ingredients for use in the manufacture of pharmaceuticals solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD

Cultivation of plants for others featuring solely cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; consultancy services relating to the cultivation of plants; cultivation and breeding for others of cannabis all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; providing health and agricultural information in the field of medical marijuana and cannabis via a website; providing medical information featuring indications and effects of particular cannabis strains, the benefits of medical marijuana, marijuana, cannabis and research related to cannabis and marijuana via a website
helius

General Information


Serial Number79285417
Word MarkHELIUS
Filing DateWednesday, December 18, 2019
Status700 - REGISTERED
Status DateTuesday, December 7, 2021
Registration Number6578316
Registration DateTuesday, December 7, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; medicinal preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; herbal preparations and extracts for medicinal use; medical cannabis and derivatives thereof namely, medicinal herbs and medicinal herb extracts; herbal supplements; all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
Goods and ServicesRetail and wholesale store services featuring cannabis medicinal herbs, cannabis oil and derivatives thereof all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; retail and wholesale store services featuring hemp and cannabis cosmetic products and accessories, food products, beverages, personal care preparations, and skin care preparations, all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; providing consumer information featuring the ratings, reviews and recommendations on marijuana and medical marijuana products via a website
Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
Goods and ServicesCultivation of plants for others featuring solely cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; consultancy services relating to the cultivation of plants; cultivation and breeding for others of cannabis all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; providing health and agricultural information in the field of medical marijuana and cannabis via a website; providing medical information featuring indications and effects of particular cannabis strains, the benefits of medical marijuana, marijuana, cannabis and research related to cannabis and marijuana via a website

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHELIUS THERAPEUTICS LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNZ

Party NameHELIUS THERAPEUTICS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAuckland 1010
NZ

Party NameHELIUS THERAPEUTICS LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAuckland 1010
NZ

Trademark Events


Event DateEvent Description
Friday, December 2, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 5, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 23, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 23, 2022FINAL DISPOSITION PROCESSED
Monday, March 7, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, January 8, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, December 18, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 7, 2021REGISTERED-PRINCIPAL REGISTER
Monday, November 8, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 20, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 20, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, October 4, 2021NOTIFICATION PROCESSED BY IB
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 1, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 1, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 16, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, August 12, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 12, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, August 12, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, July 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 15, 2021ASSIGNED TO LIE
Thursday, July 15, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 15, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, July 15, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, June 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 4, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 29, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 29, 2021FINAL REFUSAL E-MAILED
Thursday, April 29, 2021FINAL REFUSAL WRITTEN
Tuesday, March 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, October 18, 2020REFUSAL PROCESSED BY IB
Wednesday, September 30, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 30, 2020REFUSAL PROCESSED BY MPU
Thursday, September 10, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 9, 2020NON-FINAL ACTION WRITTEN
Wednesday, September 9, 2020ASSIGNED TO EXAMINER
Monday, May 25, 2020ASSIGNED TO EXAMINER
Tuesday, May 19, 2020APPLICATION FILING RECEIPT MAILED
Friday, May 15, 2020ASSIGNED TO EXAMINER
Friday, May 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 14, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB